David Soper to Follow-Up Studies
This is a "connection" page, showing publications David Soper has written about Follow-Up Studies.
Connection Strength
0.197
-
Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort. Sex Transm Dis. 2020 05; 47(5):332-337.
Score: 0.107
-
Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol. 1992 Sep; 167(3):653-60.
Score: 0.016
-
Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis. 2008 Feb; 35(2):129-35.
Score: 0.011
-
Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obstet Gynecol. 2008 Jan; 198(1):30.e1-7.
Score: 0.011
-
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006 May; 194(5):1283-9.
Score: 0.010
-
A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005 Sep 15; 162(6):585-90.
Score: 0.010
-
Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol. 2005 Jan 15; 161(2):186-95.
Score: 0.009
-
Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004 Aug; 94(8):1327-9.
Score: 0.009
-
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2002 May; 186(5):929-37.
Score: 0.008
-
Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials. 1998 Oct; 19(5):499-514.
Score: 0.006